⌘K

Login Start Free

Home/Filings/4/0001128732-18-000013

4//SEC Filing

MERZOUKI ABDERRAZZAK 4

Accession 0001128732-18-000013

CIK 0001402328other

View on SEC.gov Company Profile

Filed

Sep 13, 8:00 PM ET

Accepted

Sep 14, 10:23 AM ET

Size

4.7 KB

Accession

0001128732-18-000013

Insider Transaction Report

Form 4

Period: 2018-08-27

Sunshine Biopharma, IncSBFM

MERZOUKI ABDERRAZZAK

DirectorChief Operating Officer

Transactions

Award
Common Stock
2018-08-27$0.00/sh+38,000,000$38,000→ 118,467,000 total

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

Sunshine Biopharma, Inc

CIK 0001402328

Entity typeother

Related Parties

1

filerCIK 0001636418

Filing Metadata

Form type: 4
Filed: Sep 13, 8:00 PM ET
Accepted: Sep 14, 10:23 AM ET
Size: 4.7 KB

View on SEC.gov